Point72 Asset Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.4M | Buy |
3,336,250
+2,534,323
| +316% | +$40.5M | 0.1% | 222 |
|
|
2025
Q1 | $13.7M | Buy |
+801,927
| New | +$13.7M | 0.03% | 459 |
|
|
2024
Q2 | – | Sell |
-1,383,810
| Closed | -$44.7M | – | 1461 |
|
|
2024
Q1 | $44.7M | Sell |
1,383,810
-1,283,073
| -48% | -$41.5M | 0.11% | 216 |
|
|
2023
Q4 | $112M | Buy |
+2,666,883
| New | +$112M | 0.27% | 73 |
|
|
2023
Q3 | – | Sell |
-457,467
| Closed | -$8.68M | – | 1957 |
|
|
2023
Q2 | $8.68M | Buy |
+457,467
| New | +$8.68M | 0.03% | 548 |
|
|
2023
Q1 | – | Sell |
-435,751
| Closed | -$7.73M | – | 1838 |
|
|
2022
Q4 | $7.73M | Sell |
435,751
-1,531,549
| -78% | -$27.2M | 0.03% | 560 |
|
|
2022
Q3 | $11M | Buy |
+1,967,300
| New | +$11M | 0.04% | 450 |
|
|
2022
Q2 | – | Sell |
-459,300
| Closed | -$2.53M | – | 1168 |
|
|
2022
Q1 | $2.53M | Sell |
459,300
-441,200
| -49% | -$2.43M | 0.01% | 759 |
|
|
2021
Q4 | $7.67M | Buy |
+900,500
| New | +$7.67M | 0.03% | 551 |
|
|
2021
Q2 | – | Sell |
-187,900
| Closed | -$3.01M | – | 1005 |
|
|
2021
Q1 | $3.01M | Sell |
187,900
-70,500
| -27% | -$1.13M | 0.01% | 623 |
|
|
2020
Q4 | $11.9M | Sell |
258,400
-1,254,866
| -83% | -$58M | 0.06% | 379 |
|
|
2020
Q3 | $53.3M | Buy |
1,513,266
+1,363,623
| +911% | +$48M | 0.27% | 83 |
|
|
2020
Q2 | $3.64M | Buy |
149,643
+126,251
| +540% | +$3.07M | 0.02% | 498 |
|
|
2020
Q1 | $364K | Buy |
+23,392
| New | +$364K | ﹤0.01% | 652 |
|